Related Experiment Video
Updated: Aug 14, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
Identifying diagnostic peptides for lyme disease through epitope discovery
G A Kouzmitcheva1, V A Petrenko, G P Smith
1Division of Biological Sciences, Tucker Hall, University of Missouri, Columbia, Missouri 65211, USA.
Clinical and Diagnostic Laboratory Immunology
|January 4, 2001
Summary
Researchers identified novel peptide mimotopes for Lyme disease (LD) diagnosis using phage display. These mimotopes mimic pathogen epitopes and could form the basis of a new, cost-effective diagnostic assay for LD.
Area of Science:
- Immunology
- Biotechnology
- Infectious Diseases
Background:
- Accurate serological diagnosis of Lyme disease (LD) is crucial for effective treatment.
- Current diagnostic methods like immunoblotting can be expensive and complex.
Purpose of the Study:
- To discover novel peptide epitopes that can serve as diagnostic markers for Lyme disease.
- To develop a new diagnostic approach for LD using peptide mimotopes.
Main Methods:
- Affinity selection of peptide epitopes from random peptide libraries using serum antibodies from LD patients.
- Phage display technology was employed for peptide library screening.
- Peptide reactivity was validated against positive and negative serum panels.
Main Results:
- Identified 17 peptides with diagnostically useful binding patterns.
- Discovered eight unique sequence motifs representing pathogen-mimicking epitopes (mimotopes).
- These mimotopes did not match contiguous amino acid sequences of Borrelia burgdorferi proteins.
Conclusions:
- The identified mimotopes show potential for developing a specific and sensitive enzyme-linked immunosorbent assay (ELISA) for LD diagnosis.
- This discovery offers a cost-effective alternative to current immunoblotting tests.
- The generic methodology is applicable to diagnosing other infectious diseases, including emerging ones.
